Loading...
 
Toggle Health Problems and D

How Vitamin D, Magnesium, Omega-3 and Zinc prevent and treat COVID-19 and many other health problems – June 2021

Essential sufficiency of zinc, ω-3 polyunsaturated fatty acids, vitamin D and magnesium for prevention and treatment of COVID-19, diabetes, cardiovascular diseases, lung diseases and cancer

Biochimie. 2021 May 31;S0300-9084(21)00140-1. doi: 10.1016/j.biochi.2021.05.013
Michael J Story 1 storypharm at bigpond.com
Image

Image

Image

Image

VitaminDWiki

Yes, all of these nutrients (plus others) help fight health problems,
Yes, many studies have found various pairs to be synergistic
    however, it appears that only Vitamin D
1) Can be restored within a few days,
2) Is low cost
3) Has the fewest side effects
4) Need only be taken once a week (or once a month)
 
Note: Magnesium, Zinc, and Omega-3 each also increase the amount of vitamin D which gets to cells

COVID-19 treated by Vitamin D - studies, reports, videos

26 health factors increase the risk of COVID-19 – all are associated with low vitamin D

COVID-19 risks reduced by Vitamin D, Magnesium, Zinc, Resveratrol, Omega-3, etc. (auto-updated)

Ways to improve health - VitaminDWiki summary

Importance to Health VDW10426

Vitamin D Cofactors in a nutshell table show the importance of each

Supplement  # of
studies
Increase D
to tissue
Omega-3 346
Many benefits30%?
Magnesium 271
Many need Mg30%
Calcium 199
Reduce
Vitamin K 129
Hard bones,
soft arteries
Iron 57
Vitamin B12 49
Zinc 66
?%
Boron 30
+20%
Iodine 26
Resveratrol 41
>100% if
poor VDR
Curcumin 12
? ?% if
poor VDR

Items in both categories Immunity and Virus are listed here:


Note: Most of the Viral Infections (wikipedia) are prevented/treated by Vitamin D

Image


Magnesium

Magnesium and Vitamin D contains the following highlights

271 items in category, see also

Mg and Vitamin D

Dr. Dean

Number of studies in both of the categories of Magnesium and:

Bone 14,  Cardiovascular 13,   Diabetes 19. Depression 12,  Obesity 9,   Omega-3 25,  Zinc 18,  Pregnancy 9,  Headache 7


Overview Magnesium and vitamin D Has a venn diagram of relationship of Mg and Vit D

Magnesium not Magnesium
Vitamin D Magnesium or Vitamin D
Aging, Amytrophic Lateral Sclerosis, Alzheimer's Disease;
Asthma, Attention Deficit Disorder; Autism, Cancer, Cerebrovascular,
Chronic Fatigue, Diabetes, Hearing Loss, Heart Disease, Heart Attack, Atherosclerosis,
Cardiovascular Disease, HIV, AIDS; Hypertension; Kidney Stones,
Migraine Headache, Multiple Sclerosis, Obesity, Osteoporosis; Peripheral vascular disease;
Pregnancy-related problems,Rheumatoid Arthritis; Sports-related problems,
Vitamin D only
Acne, Allergy, Autoimmune, Bone, Breathing,
Celiac, Cognition, Colds and Flu, Cystic Fibrosis,
Dental, Fertility, Hyperparathyroid, Immunity, Kidney,
Liver, Lupus, Osteoarthritis, Pain - chronic, Parkinson,
Psoriasis, Rickets, Strokes, Sarcoidosis, Thyroid, Parathyroid,
Tuberculosis, Vision, Hair, Skin, Sports
Not Vitamin D Magnesium only
Aggressive Behavior, Alcoholism, Arrhythmia, Cerebral Palsy,
Chemical Sensitivity, Cluster Headaches; Cocaine-related Stroke; Constipation,
Cramps, Fluoride Toxicity; Head Injuries, Central Nervous System Injuries,
Magnesium Deficiency; Menopause, Mitral Valve Prolapse,
Nystagmus, Psychiatric Disorders; Repetitive Strain Injury, Sickle Cell Disease, SIDS,
Stress, Stuttering, Tetanus; Tinnitis, Sound Sensitivity; TMJ; Toxic Shock; Violence
Neither
ALL OTHER DISEASES

Omega-3

Vitamin D and Omega-3 category starts with

346 Omega-3 items in category Omega-3 and Vitamin D separately & together help with: Autism (9 studies), Depression (24 studies), Cardiovascular (30 studies), Cognition (45 studies), Pregnancy (33 studies), Infant (23 studies), Obesity (12 studies), Mortality (5 studies), Breast Cancer (5 studies), Smoking, Sleep, Stroke, Longevity, Trauma (12 studies), Inflammation (18 studies), Multiple Sclerosis (9 studies), etc

   See also - Overview: Omega-3 many benefits include helping vitamin D

Omega-3 and Virus items in VitaminDWiki (6 as of Sept 2021)

 Download the PDF from VitaminDWiki

Despite the development of a number of vaccines for COVID-19, there remains a need for prevention and treatment of the virus SARS-CoV-2 and the ensuing disease COVID-19. This report discusses the key elements of SARS-CoV-2 and COVID-19 that can be readily treated: viral entry, the immune system and inflammation, and the cytokine storm. It is shown that the essential nutrients zinc, ω-3 polyunsaturated fatty acids (PUFAs), vitamin D and magnesium provide the ideal combination for prevention and treatment of COVID-19: prevention of SARS-CoV-2 entry to host cells, prevention of proliferation of SARS-CoV-2, inhibition of excessive inflammation, improved control of the regulation of the immune system, inhibition of the cytokine storm, and reduction in the effects of acute respiratory distress syndrome (ARDS) and associated non-communicable diseases. It is emphasized that the non-communicable diseases associated with COVID-19 are inherently more prevalent in the elderly than the young, and that the maintenance of sufficiency of zinc, ω-3 PUFAs, vitamin D and magnesium is essential for the elderly to prevent the occurrence of non-communicable diseases such as diabetes, cardiovascular diseases, lung diseases and cancer. Annual checking of levels of these essential nutrients is recommended for those over 65 years of age, together with appropriate adjustments in their intake, with these services and supplies being at government cost. The cost:benefit ratio would be huge as the cost of the nutrients and the testing of their levels would be very small compared with the cost savings of specialists and hospitalization.


Portions of the PDF

Vitamin D

Vitamin D obtained from sunlight or dietary sources is catalysed by vitamin D- 25-hydroxylase in the liver to 25-hydroxyvitamin D3 (25(OH)D), the major circulating form of vitamin D. 25(OH)D is biologically inert until it is hydroxylated by the enzyme 1a-hydroxylase (CYP27B1) in the kidney to the active form 1a,25-dihydroxyvitamin D3 (calcitriol, 1a,25(OH)2D3) [62].
Calcitriol has important immunoregulatory and anti-inflammatory effects that it exerts through interaction with the vitamin D receptor (VDR). The calcitriol/VDR complex can interact with different gene transcription factors that control inflammatory responses [63]. VDR and CYP27B1 are expressed in many types of immune cells, including lymphocytes, monocytes/macrophages, dendritic cells, T and B cells [64,65], and on pulmonary epithelial cells. These immune cells can convert 25(OH)D into biologically active calcitriol [63,66]. The calcitriol/VDR complex causes transcription of the antimicrobial peptides cathelicidins and defensins. Cathelicidins disrupt bacterial cell membranes as well as enveloped viruses such as SARS-CoV-2, while defensins promote chemotaxis of inflammatory cells through increased capillary permeability [65,67].
Synthesis of vitamin D in the skin is controlled by the season, the time of the exposure during the day and the latitude [68,69]. Vitamin D is poorly synthesized above (to the north) and below (to the south) of 35° latitude during winter months [70]. Lockdowns, implemented to minimize the spread of COVID- 19, are therefore detrimental to vitamin D synthesis as people are prevented from going out from their homes and absorbing the sunshine, which has a cumulative effect in the winter months when COVID-19 is more prevalent. The Black and Asian populations produce less vitamin D as a result of a higher skin melanin content than those with white skin [71]. Excess exposure to sunlight is the major cause of skin cancer [72]. However, there is an increased incidence of skin cancer and other cancers in countries with low levels of sunlight compared with those countries with higher levels of sunlight throughout the year [73,74], supporting the proposition that sunlight is beneficial for synthesis of vitamin D and subsequent prevention of cancers. There have been a number of reports where low sun exposure has been shown to have a negative impact on a range of health issues [75-77]. The advantage of sun exposure in providing vitamin D needs to be sensibly balanced against the potential risk of skin cancer from excessive sun exposure [78]. I
In the early stages of acute inflammation, vitamin D inhibits the proliferation of Th1 and Th17 cells and their abnormal release of IFN-y, TNF-a, IL-1, IL-2, IL12, IL-23 and IL-17, IL-21 [65]. During the resolution phase of inflammation, vitamin D-mediates differentiation of Th2 cells and release of their antiinflammatory cytokines (IL-4 and IL-10), evading the organ damage that could be caused by an excessive immune response [65]. Vitamin D has powerful antiinflammatory properties that play an important role in controlling immune function in pulmonary infection; eg, it inhibits the effects of TNF-a, it inhibits NF- kB activity in immune cells, it inhibits the activation of inflammasomes and hence release of IL-1p, and it decreases expression of IL-6, a major contributor to the so-called 'cytokine storm' [65,79].
The immune response acts in concert with the inflammatory response. The innate immune system acts as the first line of defence against invading pathogens such as viruses. Calcitriol enhances that defence by recruiting neutrophils, monocytes/macrophages and dendritic cells which kill and clear the viral pathogens, ultimately initiating the adaptive immune response. This response can be overactive resulting in the cytokine storm. Calcitriol inhibits this chronic immune response by downregulating the toll-like receptors (TLRs) that identify the viral pathogens initially, and inhibits the TNF-a/NF-KB and IFN-y signalling pathways. Calcitriol shifts the T cell profile from the pro-inflammatory Th1 and Th17 forms to the anti-inflammatory Th2 and Treg forms, respectively [80]. Tregs provide a major defence against inflammation, releasing antiinflammatory cytokines IL-10 and TGF-p. Treg levels are markedly decreased in severe COVID-19 disease, in contrast to high levels of Treg correlating with reduced levels of viral disease [81].
Natural killer cells are innate immune cells and they are known to possess strong antiviral activity as well as anticancer activity [82]. The count and activity of natural killer cells have been shown to be reduced below normal in COVID-19 patients, and vitamin D has been found to increase the activity of natural killer cells [82].
Although there is inconsistency in the data, it is apparent that vitamin D deficiency is influential in increasing risk of acute respiratory tract infections [83], particularly when considering the decrease in natural synthesis of vitamin D in winter-time when acute respiratory infections are most prevalent. Ali [84] conducted a study of COVID-19 cases and mortality in 20 European countries, finding that vitamin D status correlated negatively with COVID-19 cases but not with mortality. The effectiveness of vitamin D sufficiency in reducing risk of acute viral respiratory tract infections and pneumonia was also shown. Similar results were reported by Kara and co-workers [85], who also discussed the link between latitude, temperature and humidity and season on viral respiratory tract infections.
Allegra and co-workers [86] reported on the deficiency and supplementation of a range of vitamins including vitamin D, in particular in correlating hypovitaminosis with risk of contracting COVID-19 and associated mortality. They reported that there were positive and indeterminate results in their analysis of multiple studies. Vitamin D levels were particularly reduced in the ageing populations of Italy, Spain, and Switzerland, which were the most susceptible populations in relation to SARS-CoV-2 infection [87]. Additionally, Annweiler and co-workers [88] analysed a range of reports with the conclusion that inverse correlations were found between 25(OH)D levels in patients and COVID-19 incidence and mortality. Other reports have also covered the influence of vitamin D on outcomes of COVID-19 patients with the typical finding that vitamin D supplementation leads to an improved outcome for these patients and that vitamin D deficiency increases the risk and susceptibility for severe COVID- 19 disease and mortality [69,84,87,89-99].
In another review, Lau and co-workers [100] found that vitamin D deficiency was highly prevalent in patients with severe COVID-19, which correlated in turn with obesity, male sex, advanced age, population concentration in northern climates, coagulopathy and immune dysfunction. A further meta-analysis found that vitamin D deficiency increased risk of severe infections and mortality of the critically ill [101]. Deficiency of vitamin D has been further claimed to increase the risk of contracting osteoporosis, cancer, diabetes, multiple sclerosis, hypertension, and inflammatory and immunological diseases [102]. Although vitamin D and the benefits of supplementation in preventing cancer have been discussed previously [1], it is of note that a number of researchers have demonstrated that the risk of cancer incidence and fatality is reduced with vitamin D supplementation [eg, 103-105]. The mechanism of action of vitamin D in reducing cancer risk has also been addressed in a number of reviews [eg, 106-108].
It has been specified that a reasonable level of 25(OH)D in serum is at least 30 ng/mL (75 nmol/L) [93,109], with a preference for 40-60 ng/mL (100-150 nmol/L) to ensure good health, particularly in the elderly [69,110].
In summary, vitamin D impedes the entry and replication of SARS-CoV-2, reduces the levels of pro-inflammatory cytokines, increases the levels of antiinflammatory cytokines and increases the production of natural antimicrobial peptides [111].

Discussion

COVID-19 and its virus SARS-CoV-2 have provided an ideal opportunity to reset the approach to prevention and treatment of non-communicable diseases, particularly those that occur predominantly in the aged. COVID-19 has been shown to be linked to comorbidities such as senescence occurring in the aged, obesity/diabetes which are more severe in the aged, and cardiovascular diseases and chronic pulmonary diseases which are more prevalent in the aged, as well as cancers. It is therefore opportune to examine carefully the prevention and treatment of COVID-19 and those diseases, with particular attention to those features and characteristics that are common to these diseases. The most outstanding common features are inflammation and overactivity of the innate and adaptive immune systems. Control of inflammation and the immune system are fundamentally dependent on sufficiency of the essential nutrients zinc, q-3 PUFAs, vitamin D and magnesium.
This paper has been directed towards an appreciation of the benefits of having sufficiency of zinc,⑴-3 PUFAs, vitamin D and magnesium. These four components are essential as they are natural to the normal functioning of cells and multiple other components of the human body. They are extremely safe when supplemented in a controlled manner. Control in the aged (eg, 65 years and older) can be maintained by annual analyses of their serum levels. This canbe achieved with government support, as well as by government supplies of supplements where necessary. The cost of this service to those over 65 would be small compared with the potential savings in hospitalization and critical care costs. As an example, a German estimate of the effect of supplementing vitamin D alone on the cost savings of cancer alone in Germany showed a cost saving of approximately €254 million per year with a prevention of almost 30,000 deaths to cancer per year [351].
Zinc,⑴-3 PUFAs, vitamin D and magnesium are pleiotropic as they allow, and in fact boost, the functioning of granulocytes such as mast cells, neutrophils and eosinophils, as well as monocytes/macrophages, dendritic cells, T cells and B cells in normal conditions and when there are minor invasions of pathogens such as minor viral and bacterial infections. In contrast, zinc, q-3 PUFAs, vitamin D and magnesium all act to suppress hyperinflammation and major disruptions of the immune system that occur when there is a significant invasion by viral or bacterial pathogens such as SARS-CoV-2 or non-communicable diseases such as diabetes, cardiovascular disease or chronic pulmonary disease. In these situations, zinc,⑴-3 PUFAs, vitamin D and magnesium have the ability to suppress excessive inflammation and dysregulation of the immune system. These nutrients are therefore essential in all aspects; when present in sufficiency they are directed towards ensuring good health for humans at all times and for all ages. This is not normally the case with non-natural drugs that are prescribed for treatment of particular pathological conditions.
Vaccines are rarely 100% in their prevention of transmission and their prevention of humans contracting the particular disease; there are potential problems with mutations and diminution of their effectiveness. It is of note that vaccines perform their function through the adaptive immune system, whilst zinc,⑴-3 PUFAs, vitamin D and magnesium affect both the innate and adaptive immune systems. Supplementation of the four nutrients in treatment of COVID- 19 is therefore desirable, especially if this supplementation is beneficial in preventing or treating non-communicable diseases or reducing the adverse effects of ageing.

References

  1. Story MJ (2021). Zinc, q-3 polyunsaturated fatty acids and vitamin D: An essential combination for prevention and treatment of cancers. Biochimie 181:100-122    https://doi.org/10.1016/j.biochi.2020.11.019   behind a paywall
  2. “Global Status Report on Non-Communicable Diseases,” WHO. 2010. https://www.who.int/nmh/publications/ncd report full en.pdf
  3. Pecora F, Persico F, Argentiero A, Neglia C, Esposito S (2020). The role of micronutrients in support of the immune response against viral infections. Nutrients 12(10):E3198
  4. Szabo Z, Marosvolgyi T, Szabo E, Bai P, Figler M, Verzar Z (2020). The potential beneficial effect of EPA and DHA supplementation managing cytokine storm in coronavirus disease. Front Physiol 11:752
  5. Calder PC, Carr AC, Gombart AF, Eggersdorfer M (2020). Optimal nutritional status for a well-functioning immune system is an important factor to protect against viral infections. Nutrients 12(4):1181
  6. Iddir M, Brito A, Dingeo G, Fernandez Del Campo SS, Samouda H, La Frano MR, et al (2020). Strengthening the immune system and reducing inflammation and oxidative stress through diet and nutrition: Considerations during the COVID-19 crisis. Nutrients 12(6):1562
  7. Mammadova-Bach E, Braun A (2019). Zinc homeostasis in platelet-related diseases. Int J Mol Sci 20(21): 5258
  8. Prasad AS (2008). Zinc in human health: Effect of zinc on immune cells. Mol Med 14(5-6):353-7
  9. Bao B, Prasad AS, Beck FW, Fitzgerald JT, Snell D, Bao GW, et al (2010). Zinc decreases C-reactive protein, lipid peroxidation, and inflammatory cytokines in elderly subjects: a potential implication of zinc as an atheroprotective agent. Am J Clin Nutr 91(6):1634-41
  10. Prasad AS, Beck FW, Bao B, Fitzgerald JT, Snell DC, Steinberg JD, et al (2007). Zinc supplementation decreases incidence of infections in the elderly: effect of zinc on generation of cytokines and oxidative stress. Am J Clin Nutr 85(3):837-44
  11. Gao H, Dai W, Zhao L, Min J, Wang F (2018). The role of zinc and zinc homeostasis in macrophage function. J Immunol Res 2018:6872621
  12. Skalny AV, Rink L, Ajsuvakova OP, Aschner M, Gritsenko VA, Alekseenko SI, et al (2020). Zinc and respiratory tract infections: Perspectives for COVID-19 (Review). Int J Mol Med 46(1): 17-26
  13. Kloubert V, Rink L (2015). Zinc as a micronutrient and its preventive role of oxidative damage in cells. Food Funct 6(10):3195-3204
  14. Prasad AS (2013). Discovery of human zinc deficiency: its impact on human health and disease. Adv Nutr 4(2):176-90
  15. Shankar AH, Prasad AS (1998). Zinc and immune function: The biological basis of altered resistance to infection. Am J Clin Nutr 68(2 Suppl):447S- 463S
  16. Haase H, Rink L (2009). The immune system and the impact of zinc during aging. Immun Ageing 6:9
  17. Mayor-Ibarguren A, Busca-Arenzana C, Robles-Marhuenda A (2020). A hypothesis for the possible role of zinc in the immunological pathways related to COVID-19 infection. Front Immunol 11:1736
  18. Haase H, Rink L (2014). Zinc signals and immune function. Biofactors 40(1):27-40
  19. Gombart AF, Pierre A, Maggini S (2020). A review of micronutrients and the immune system-working in harmony to reduce the risk of infection. Nutrients 12(1):236
  20. Meydani SN, Barnett JB, Dallal GE, Fine BC, Jacques PF, Leka LS, et al (2007). Serum zinc and pneumonia in nursing home elderly. Am J Clin Nutr 86(4):1167-73
  21. Barnett JB, Hamer DH, Meydani SN (2010). Low zinc status: a new risk factor for pneumonia in the elderly? Nutr Rev 68(1):30-37
  22. Braun LA, Ou R, Kure C, Trang A, Rosenfeldt F (2018). Prevalence of zinc deficiency in cardiac surgery patients. Heart Lung Circ 27(6): 760-762
  23. Derwand R, Scholz M (2020). Does zinc supplementation enhance the clinical efficacy of chloroquine/hydroxychloroquine to win today's battle against COVID-19? Med Hypotheses 142:109815
  24. George MM, Subramanian Vignesh K, Landero Figueroa JA, Caruso JA, Deepe GS Jr (2016). Zinc induces dendritic cell tolerogenic phenotype and skews regulatory T cell-Th17 balance. J Immunol 197(5):1864-76
  25. Prasad AS, Bao B, Beck FW, Sarkar FH (2011). Zinc-suppressed inflammatory cytokines by induction of A20-mediated inhibition of nuclear factor-KB. Nutrition 27(7-8):816-23
  26. McGonagle D, Sharif K, O'Regan A, Bridgewood C (2020). The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease. Autoimmun Rev 19(6):102537
  27. Alexander J, Tinkov A, Strand TA, Alehagen U, Skalny A, Aaseth J (2020). Early nutritional interventions with zinc, selenium and vitamin D for raising anti-viral resistance against progressive COVID-19. Nutrients 12(8):2358
  28. Arentz S, Yang G, Goldenberg J, Beardsley J, Myers SP, Mertz D, et al (2020). Zinc for the prevention and treatment of SARS-CoV-2 and other acute viral respiratory infections: a rapid review. Adv Integr Med 7(4):252- 260
  29. Zabetakis I, Lordan R, Norton C, Tsoupras A (2020). COVID-19: The inflammation link and the role of nutrition in potential mitigation. Nutrients 12(5):1466
  30. Stefanidou M, Maravelias C, Dona A, Spiliopoulou C (2006). Zinc: a multipurpose trace element. Arch Toxicol 80(1):1-9
  31. te Velthuis AJ, van den Worm SH, Sims aC, Baric RS, Snijder EJ, van Hemert MJ (2010). Zn(2+) inhibits coronavirus and arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture. PLoS Pathog 6(11):e1001176
  32. Rajaiah R, Abhilasha KV, Shekar MA, Vogel SN, Vishwanath BS (2020). Evaluation of mechanisms of action of re-purposed drugs for treatment of COVID-19. Cell Immunol 358:104240
  33. Doboszewska U, Wlaz P, Nowak G, Mlyniec K (2020). Targeting zinc metalloenzymes in coronavirus disease 2019. Br J Pharmacol 177(21):4887-4898
  34. Dabbagh-Bazarbachi H, Clergeaud G, Quesada IM, Ortiz M, O'Sullivan CK, Fernandez-Larrea JB (2014). Zinc ionophore activity of quercetin and epigallocatechin-gallate: from Hepa 1-6 cells to a liposome model. J Agric Food Chem 62(32):8085-93
  35. Brooks HA, Gardner D, Poyser JP, King TJ (1984). The structure and absolute stereochemistry of zincophorin (antibiotic M144255): a monobasic carboxylic acid ionophore having a remarkable specificity for divalent cations. J Antibiot (Tokyo) 37(11):1501-4
  36. Rizzo E (2020). Ivermectin, antiviral properties and COVID-19: a possible new mechanism of action. Naunyn Schmiedebergs Arch Pharmacol 393(7):1153-1156
  37. ClinicalTrials.gov. https://clinicaltrials.gov/ct2/home
  38. Pal A, Squitti R, Picozza M, Pawar A, Rongioletti M, Dutta AK, et al (2021). Zinc and COVID-19: Basis of current clinical trials. Biol Trace Elem Res Ahead of print
  39. Kumar A, Kubota Y, Chernov M, Kasuya H (2020). Potential role of zinc supplementation in prophylaxis and treatment of COVID-19. Med Hypotheses 144:109848
  40. Wessels I, Rolles B, Rink L (2020). The potential impact of zinc supplementation on COVID-19 pathogenesis. Front Immunol 11:1712
  41. Roscioli E, Jersmann HP, Lester S, Badiei A, Fon A, Zalewski P, et al (2017). Zinc deficiency as a codeterminant for airway epithelial barrier dysfunction in an ex vivo model of COPD. Int J Chron Obstruct Pulmon Dis 12:35033510
  42. Wessels I, Pupke JT, von Trotha KT, Gombert A, Himmelsbach A, Fischer HJ, et al (2020). Zinc supplementation ameliorates lung injury by reducing neutrophil recruitment and activity. Thorax 75(3):253-261
  43. Finzi E (2020). Treatment of SARS-CoV-2 with high dose oral zinc salts: A report on four patients. Int J Infect Dis 99:307-309
  44. Carlucci PM, Ahuja T, Petrilli C, Rajagopalan H, Jones S, Rahimian J (2020). Zinc sulfate in combination with a zinc ionophore may improve outcomes in hospitalized COVID-19 patients. J Med Microbiol 69(10):1228-1234
  45. Jothimani D, Kailasam E, Danielraj S, Nallathambi B, Ramachandran H, Sekar P, et al (2020). COVID-19: Poor outcomes in patients with zinc deficiency. Int J Infect Dis 100:343-349
  46. Razzaque MS (2020). COVID-19 pandemic: Can maintaining optimal zinc balance enhance host resistance? Tohoku J Exp Med 251(3): 175-181
  47. Simopoulos AP (2002). The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed Pharmacother 56(8):365-79
  48. Simopoulos AP (2008). The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp Biol Med (Maywood) 233(6):674-88
  49. Blondeau N, Lipsky RH, Bourourou M, Duncan MW, Gorelick PB, Marini AM (2015). Alpha-linolenic acid: an omega-3 fatty acid with neuroprotective properties-ready for use in the stroke clinic? Biomed Res Int 2015:519830
  50. Das UN (2020). Can bioactive lipids inactivate coronavirus (COVID-19)? Arch Med Res 51(3):282-286
  51. Weill P, Plissonneau C, Legrand P, Rioux V, Thibault R (2020). May omega- 3 fatty acid dietary supplementation help reduce severe complications in Covid-19 patients? Biochimie 179:275-280
  52. Schiessel DL, Yamazaki RK, Kryczyk M, Coelho I, Yamaguchi AA, Pequito DC, et al (2015). a-Linolenic fatty acid supplementation decreases tumor growth and cachexia parameters in Walker 256 tumor-bearing rats. Nutr Cancer 67(5):839-46
  53. Gutierrez S, Svahn SL, Johansson ME (2019). Effects of omega-3 fatty acids on immune cells. Int J Mol Sci 20(20):5028
  54. Serhan CN, Chiang N, Van Dyke TE (2008). Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 8(5):349-61
  55. Rius B, Lopez-Vicario C, Gonzalez-Periz A, Moran-Salvador E, Garcfa-Alonso V, Claria J, et al (2012). Resolution of inflammation in obesity-induced liver disease. Front Immunol 3:257
  56. Lu Y, Liu DX, Tam JP (2008). Lipid rafts are involved in SARS-CoV entry into Vero E6 cells. Biochem Biophys Res Commun 369(2): 344-349
  57. Li GM, Li YG, Yamate M, Li SM, Ikuta K (2007). Lipid rafts play an important role in the early stage of severe acute respiratory syndrome-coronavirus life cycle. Microbes Infect 9(1):96-102
  58. Goc A, Niedzwiecki A, Rath M (2021). Polyunsaturated q-3 fatty acids inhibit ACE2-controlled SARS-CoV-2 binding and cellular entry. Research Square Ahead of print
  59. Fritsche K (2006). Fatty acids as modulators of the immune response. Annu Rev Nutr 26:45-73
  60. Vedin I, Cederholm T, Freund Levi Y, Basun H, Garlind A, et al (2008). Effects of docosahexaenoic acid-rich n-3 fatty acid supplementation on cytokine release from blood mononuclear leukocytes: The OmegAD study. Am J Clin Nutr 87(6):1616-22
  61. Kiecolt-Glaser JK, Belury MA, Andridge R, Malarkey WB, Hwang BS, Glaser R (2012). Omega-3 supplementation lowers inflammation in healthy middle-aged and older adults: a randomized controlled trial. Brain Behav Immun 26(6):988-95
  62. Chiang KC, Chen TC (2009). Vitamin D for the prevention and treatment of pancreatic cancer. World J Gastroenterol 15(27):3349-54
  63. Barragan M, Good M, Kolls JK (2015). Regulation of dendritic cell function by vitamin D. Nutrients 7(9):8127-51
  64. Sassi F, Tamone C, D'Amelio P (2018). Vitamin D: Nutrient, hormone, and immunomodulator. Nutrients 10(11):1656
  65. Xu Y, Baylink DJ, Chen CS, Reeves ME, Xiao J, Lacy C, et al (2020). The importance of vitamin D metabolism as a potential prophylactic, immunoregulatory and neuroprotective treatment for COVID-19. J Transl Med 18(1):322
  66. Ohadian Moghadam S (2020). A review on currently available potential therapeutic options for COVID-19. Int J Gen Med 13:443-467
  67. Munshi R, Hussein MH, Toraih EA, Elshazli RM, Jardak C, Sultana N, et al (2020). Vitamin D insufficiency as a potential culprit in critical COVID-19 patients. J Med Virol Ahead of print
  68. Chaabouni M, Feki W, Chaabouni K, Kammoun S (2020). Vitamin D supplementation to prevent COVID-19 in patients with COPD: A research perspective. Adv Respir Med 88(4):364-365
  69. Grant WB, Lahore H, McDonnell SL, Baggerly CA, French CB, Aliano JL, et al (2020). Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths. Nutrients 12(4):988
  70. Rhodes JM, Subramanian S, Laird E, Kenny RA (2020). Editorial: low population mortality from COVID-19 in countries south of latitude 35 degrees North supports vitamin D as a factor determining severity. Aliment Pharmacol Ther 51(12):1434-1437
  71. Mandal AKJ, Baktash V, Hosack T, Missouris CG (2020). Vitamin D status and COVID-19 in older adults. Aging Clin Exp Res 32(11):2425-2426
  72. Dixon KM, Tongkao-On W, Sequeira VB, Carter SE, Song EJ, Rybchyn MS, Gordon-Thomson C, Mason RS (2013). Vitamin D and death by sunshine. Int J Mol Sci 14(1):1964-77
  73. Garland CF, Garland FC, Gorham ED (2006). The role of vitamin D in cancer prevention. Am J Public Health 96(2):252-261
  74. Macdonald HM (2013). Contributions of sunlight and diet to vitamin D status. Calcif Tissue Int 92(2):163-76
  75. Dobnig H (2011). A review of the health consequences of the vitamin D deficiency pandemic. J Neurol Sci 311(1-2): 15-8
  76. Hoel DG, Berwick M, de Gruijl FR, Holick MF (2016). The risks and benefits of sun exposure 2016. Dermatoendocrinol 8(1):e1248325
  77. van der Rhee H, de Vries E, Coomans C, van de Velde P, Coebergh JW (2016). For better or for worse? A review of positive and negative effects of sun exposure. Cancer Res Front 2(2):156-183
  78. Green RJ, Samy G, Miqdady MS, El-Hodhod M, Akinyinka OO, Saleh G, et al (2015). Vitamin D deficiency and insufficiency in Africa and the Middle East, despite year-round sunny days. S Afr Med J 105(7):603-5
  79. Li H, Zhong X, Li W, Wang Q (2019). Effects of 1,25-dihydroxyvitamin D3 on experimental periodontitis and AhR/NF-KB/NLRP3 inflammasome pathway in a mouse model. J Appl Oral Sci 27:e20180713
  80. Bilezikian JP, Bikle D, Hewison M, Lazaretti-Castro M, Formenti AM, Gupta A, et al (2020). MECHANISMS IN ENDOCRINOLOGY: Vitamin D and COVID- 19. Eur J Endocrinol 183(5):R133-R147
  81. Simonson W (2020). Vitamin D and Coronavirus. Geriatr Nurs 41(4):496- 497
  82. Al-Ani M, Elemam NM, Hundt JE, Maghazachi AA (2020). Drugs for multiple sclerosis activate natural kKiller cells: Do they protect against COVID-19 infection? Infect Drug Resist 13:3243-3254
  83. Adams KK, Baker WL, Sobieraj DM (2020). Myth busters: Dietary supplements and COVID-19. Ann Pharmacother 54(8):820-826
  84. Ali N (2020). Role of vitamin D in preventing of COVID-19 infection, progression and severity. J Infect Public Health 13(10):1373-1380
  85. Kara M, Ekiz T, Ricci V, Kara O, Chang KV, Ozgakar L (2020). 'Scientific Strabismus' or two related pandemics: coronavirus disease and vitamin D deficiency. Br J Nutr 124(7):736-741
  86. Allegra A, Tonacci A, Pioggia G, Musolino C, Gangemi S (2020). Vitamin deficiency as risk factor for SARS-CoV-2 infection: correlation with susceptibility and prognosis. Eur Rev Med Pharmacol Sci 24(18):9721-9738
  87. Ilie PC, Stefanescu S, Smith L (2020). The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality. Aging Clin Exp Res 32(7):1195-1198
  88. Annweiler C, Cao Z, Sabatier JM (2020). Point of view: Should COVID-19 patients be supplemented with vitamin D? Maruritas 140:24-26
  89. Baktash V, Hosack T, Patel N, Shah S, Kandiah P, Van Den Abbeele K, et al (2021). Vitamin D status and outcomes for hospitalised older patients with COVID-19. Postgrad Med J Ahead of print
  90. Carpagnano GE, Di Lecce V, Quaranta VN, Zito A, Buonamico E, Capozza E, et al (2020). Vitamin D deficiency as a predictor of poor prognosis in patients with acute respiratory failure due to COVID-19. J Endocrinol Invest 9:1-7
  91. Hadizadeh F (2021). Supplementation with vitamin D in the COVID-19 pandemic? Nutr Rev 79(2):200-208
  92. Kaufman HW, Niles JK, Kroll MH, Bi C, Holick MF (2020). SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D levels. PLoS One 15(9):e0239252
  93. Maghbooli Z, Sahraian MA, Ebrahimi M, Pazoki M, Kafan S, Tabriz HM, et al (2020). Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection. PLoS One 15(9):e0239799
  94. Merzon E, Tworowski D, Gorohovski A, Vinker S, Golan Cohen A, Green I, et al (2020). Low plasma 25(OH) vitamin D level is associated with increased risk of COVID-19 infection: an Israeli population-based study. FEBS J 287(17):3693-3702
  95. Moozhipurath RK, Kraft L, Skiera B (2020). Evidence of protective role of Ultraviolet-B (UVB) radiation in reducing COVID-19 deaths. Sci Rep 10(1):17705
  96. Weir EK, Thenappan T, Bhargava M, Chen Y (2020). Does vitamin D deficiency increase the severity of COVID-19? Clin Med (Lond) 20(4):e107- e108
  97. Zemb P, Bergman P, Camargo CA Jr, Cavalier E, Cormier C, Courbebaisse M, et al (2020). Vitamin D deficiency and the cOvid-19 pandemic. J Glob Antimicrob Resist 22:133-134
  98. Entrenas Castillo M, Entrenas Costa LM, Vaquero Barrios JM, Alcala Diaz JF, Lopez Miranda J, Bouillon R, et al (2020). Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study. J Steroid Biochem Mol Biol 203:105751
  99. Tarazona-Santabalbina FJ, Cuadra L, Cancio JM, Carbonell FR, Garrote JMP, Casas-Herrero A, Martfnez-Velilla N, Serra-Rexach JA, Formiga F (2021). VitaminD supplementation for the prevention and treatment of COVID-19: a position statement from the Spanish Society of Geriatrics and Gerontology. Rev Esp Geriatr Gerontol Ahead of print
  100. Lau FH, Majumder R, Torabi R, Saeg F, Hoffman R, Cirillo JD, et al (2021). Vitamin D insufficiency is prevalent in severe COVID-19. MedRxiv preprint Ahead of print
  101. de Haan K, Groeneveld AB, de Geus HR, Egal M, Struijs A (2014). Vitamin D deficiency as a risk factor for infection, sepsis and mortality in the critically ill: systematic review and meta-analysis. Crit Care 18(6):660
  102. Claro da Silva T, Hiller C, Gai Z, Kullak-Ublick GA (2016). Vitamin D3 transactivates the zinc and manganese transporter SLC30A10 via the Vitamin D receptor. J Steroid Biochem Mol Biol 163:77-87
  103. McDonnell SL, Baggerly CA, French CB, Baggerly LL, Garland CF, Gorham ED, et al (2018). Breast cancer risk markedly lower with serum 25- hydroxyvitamin D concentrations >60 vs <20 ng/ml (150 vs 50 nmol/L): Pooled analysis of two randomized trials and a prospective cohort. PLoS One 13(6):e0199265
  104. McCullough ML, Zoltick ES, Weinstein SJ, Fedirko V, Wang M, Cook NR, et al (2019). Circulating vitamin D and colorectal cancer risk: An international pooling project of 17 cohorts. J Natl Cancer Inst 111(2):158-169
  105. Chandler PD, Chen WY, Ajala ON, Hazra A, Cook N, Bubes V, et al (2020). Effect of vitamin D3 supplements on development of advanced cancer: A secondary analysis of the VITAL randomized clinical trial. JAMA Netw Open 3(11):e2025850
  106. Moukayed M, Grant WB (2017). The roles of UVB and vitamin D in reducing risk of cancer incidence and mortality: A review of the epidemiology, clinical trials, and mechanisms. Rev Endocr Metab Disord 18(2):167-182
  107. Ma Y, Johnson CS, Trump DL (2016). Mechanistic insights of vitamin D anticancer effects. Vitam Horm 100:395-431
  108. Abu El Maaty MA, Wolfl S (2017). Effects of 1,25(OH)2D3 on cancer cells and potential applications in combination with established and putative anti-cancer agents. Nutrients 9(1):87
  109. D'Avolio A, Avataneo V, Manca A, Cusato J, De Nicolo A, Lucchini R, et al (2020). 25-Hydroxyvitamin D concentrations are lower in patients with positive PCR for SARS-CoV-2. Nutrients 12(5):1359
  110. Charoenngam N, Holick MF (2020). Immunologic Effects of vitamin D on human health and disease. Nutrients 12(7):E2097
  111. Kumar R, Rathi H, Haq A, Wimalawansa SJ, Sharma A (2021). Putative roles of vitamin D in modulating immune response and immunopathology associated with COVID-19. Virus Res 292:198235
  112. Dominguez LJ, Veronese N, Guerrero-Romero F, Barbagallo M (2021). Magnesium in infectious diseases in older people. Nutrients 13(1):180
  113. Iotti S, Wolf F, Mazur A, Maier JA (2020). The COVID-19 pandemic: is there a role for magnesium? Hypotheses and perspectives. Magnes Res 33(2):21- 27
  114. Micke O, Vormann J, Kisters K (2021). Magnesium and COVID-19 - Some further comments - A commentary on Wallace TC. Combating COVID-19 and building immune resilience: A potential role for magnesium nutrition? J Am Coll Nutr Ahead of print
  115. Alamdari NM, Afaghi S, Rahimi FS, Tarki FE, Tavana S, Zali A, et al (2020). Mortality risk factors among hospitalized COVID-19 patients in a major referral center in Iran. Tohoku J Exp Med 252(1):73-84
  116. Quilliot D, Bonsack O, Jaussaud R, Mazur A (2020). Dysmagnesemia in Covid-19 cohort patients: prevalence and associated factors. Magnes Res 33(4):114-122
  117. Zeng HL, Yang Q, Yuan P, Wang X, Cheng L (2021). Associations of essential and toxic metals/metalloids in whole blood with both disease severity and mortality in patients with COVID-19. FASEB J 35(3):e21392
  118. Costello RB, Nielsen F (2017). Interpreting magnesium status to enhance clinical care: key indicators. Curr Opin Clin Nutr Metab Care 20(6):504-511
  119. Nielsen FH (2018). Magnesium deficiency and increased inflammation: current perspectives. J Inflamm Res 11:25-34
  120. Tang CF, Ding H, Jiao RQ, Wu XX, Kong LD (2020). Possibility of magnesium supplementation for supportive treatment in patients with COVID-19. Eur J Pharmacol 886:173546
  121. Wallace TC (2020). Combating COVID-19 and building immune resilience: A potential role for magnesium nutrition? J Am Coll Nutr 39(8):685-693
  122. DiNicolantonio JJ, O'Keefe JH (2021). Magnesium and Vitamin D Deficiency as a Potential Cause of Immune Dysfunction, Cytokine Storm and Disseminated Intravascular Coagulation in covid-19 patients. Mo Med 118(1):68-73
  123. Dai Q, Zhu X, Manson JE, Song Y, Li X, Franke AA, et al (2018). Magnesium status and supplementation influence vitamin D status and metabolism: results from a randomized trial. Am J Clin Nutr 108(6):1249-1258
  124. de Baaij JH, Hoenderop JG, Bindels RJ (2015). Magnesium in man: implications for health and disease. Physiol Rev 95(1):1-46
  125. Maier JA, Castiglioni S, Locatelli L, Zocchi M, Mazur A (2020). Magnesium and inflammation: Advances and perspectives. Semin Cell Dev Biol Ahead of print
  126. Chacko SA, Song Y, Nathan L, Tinker L, de Boer IH, Tylavsky F, et al (2010). Relations of dietary magnesium intake to biomarkers of inflammation and endothelial dysfunction in an ethnically diverse cohort of postmenopausal women. Diabetes Care 33(2):304-10
  127. Qu X, Jin F, Hao Y, Li H, Tang T, Wang H, et al (2013). Magnesium and the risk of cardiovascular events: a meta-analysis of prospective cohort studies. PLoS One 8(3):e57720
  128. Zipeto D, Palmeira JDF, Arganaraz GA, Arganaraz ER (2020). aCe2/ADAM17/TMPRSS2 interplay may be the main risk factor for C〇VID- 19. Front Immunol 11:576745
  129. Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh CL, Abiona O, et al (2020). Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 367(6483):1260-1263
  130. Martin Gimenez VM, Inserra F, Tajer CD, Mariani J, Ferder L, Reiter RJ, et al (2020). Lungs as target of COVID-19 infection: Protective common molecular mechanisms of vitamin D and melatonin as a new potential synergistic treatment. Life Sci 254:117808
  131. Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS (2020). Angiotensinconverting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med 46(4):586-590
  132. Hathaway D, Pandav K, Patel M, Riva-Moscoso A, Singh BM, Patel A, et al (2020). Omega 3 fatty acids and COVID-19: A comprehensive review. Infect Chemother 52(4):478-495
  133. Aygun H (2020). Vitamin D can prevent COVID-19 infection-induced multiple organ damage. Naunyn Schmiedebergs Arch Pharmacol 393(7):1157-1160
  134. Kumar D, Gupta P, Banerjee D (2020). Letter: does vitamin D have a potential role against COVID-19? Aliment Pharmacol Ther 52(2):409-411
  135. Xu J, Yang J, Chen J, Luo Q, Zhang Q, Zhang H (2017). Vitamin D alleviates lipopolysaccharide-induced acute lung injury via regulation of the renin-angiotensin system. Mol Med Rep 16(5):7432-7438
  136. Xiao D, Li X, Su X, Mu D, Qu Y (2020). Could SARS-CoV-2-induced lung injury be attenuated by vitamin D? Int J Infect Dis 102:196-202
  137. Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al (2020). A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579(7798):270-273
  138. Biggs L, Yu C, Fedoric B, Lopez AF, Galli SJ, Grimbaldeston MA (2010). Evidence that vitamin D(3) promotes mast cell-dependent reduction of chronic UVB-induced skin pathology in mice. J Exp Med 207(3):455-63
  139. Skrajnowska D, Bobrowska-Korczak B (2019). Role of zinc in immune system and anti-cancer defense mechanisms. Nutrients 11(10):2273
  140. Mohan M, Cherian JJ, Sharma A (2020). Exploring links between vitamin D deficiency and COVID-19. PLoS Pathog 16(9):e1008874
  141. Stone KD, Prussin C, Metcalfe DD (2010). IgE, mast cells, basophils, and eosinophils. J Allergy Clin Immunol 125(2 Suppl 2):S73-80
  142. Kempuraj D, Selvakumar GP, Ahmed ME, Raikwar SP, Thangavel R, Khan A, et al (2020). COVID-19, mast cells, cytokine storm, psychological stress, and neuroinflammation. Neuroscientist 26(5-6):402-414
  143. Graham AC, Temple RM, Obar JJ (2015). Mast cells and influenza A virus: association with allergic responses and beyond. Front Immunol 6:238
  144. Wang X, Kulka M (2015). n-3 Polyunsaturated fatty acids and mast cell activation. J Leukoc Biol 97(5):859-71
  145. Mukai K, Tsai M, Saito H, Galli SJ (2018). Mast cells as sources of cytokines, chemokines, and growth factors. Immunol Rev 282(1):121-150
  146. Kawakami T, Ando T, Kimura M, Wilson BS, Kawakami Y (2009). Mast cells in atopic dermatitis. Curr Opin Immunol 21(6):666-78
  147. Baeke F, Takiishi T, Korf H, Gysemans C, Mathieu C (2010). Vitamin D: modulator of the immune system. Curr Opin Pharmacol 10(4):482-96
  148. Meftahi GH, Jangravi Z, Sahraei H, Bahari Z (2020). The possible pathophysiology mechanism of cytokine storm in elderly adults with COVID- 19 infection: the contribution of "inflame-aging". Inflamm Res 69(9):825- 839
  149. Jafarzadeh A, Chauhan P, Saha B, Jafarzadeh S, Nemati M (2020). Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: Lessons from SARS and MERS, and potential therapeutic interventions. Life Sci 257:118102
  150. Harihar1an A, Hakeem AR, Radhakrishnan S, Reddy MS, Rela M (2020). The role and therapeutic potential of NF-kappa-B pathway in severe COVID- 19 patients. Inflammopharmacology 7:1-10
  151. Wensveen FM, Valentic S, Sestan M, Turk Wensveen T, Polic B (2015). The "Big Bang" in obese fat: Events initiating obesity-induced adipose tissue inflammation. Eur J Immunol 45(9):2446-56
  152. Blanchard C, Rothenberg,ME (2009). Biology of the eosinophil. Adv Immunol 101:81-121
  153. Hogan SP, Rosenberg HF, Moqbel R, Phipps S, Foster PS, Lacy P, Kay AB, Rothenberg ME (2008). Eosinophils: biological properties and role in health and disease. Clin Exp Allergy 38(5):709-50
  154. Davoine F, Lacy P (2014). Eosinophil cytokines, chemokines, and growth factors: emerging roles in immunity. Front Immunol 5:570
  155. Pacha O, Sallman MA, Evans SE (2020). COVID-19: a case for inhibiting IL- 17? Nat Rev Immunol 20(6):345-346
  156. Aggarwal N, Korenbaum E, Mahadeva R, Immenschuh S, Grau V, Dinarello CA, et al (2016). a-Linoleic acid enhances the capacity of a-1 antitrypsin to inhibit lipopolysaccharide-induced IL-1p in human blood neutrophils. Mol Med 22:680-93
  157. Mantovani A, Cassatella MA, Costantini C, Jaillon S (2011). Neutrophils in the activation and regulation of innate and adaptive immunity. Nat Rev Immunol 11(8):519-31
  158. Tecchio C, Micheletti A, Cassatella MA (2014). Neutrophil-derived cytokines: facts beyond expression. Front Immunol 5:508
  159. Lau YL, Peiris JS, Law HK (2012). Role of dendritic cells in SARS coronavirus infection. Hong Kong Med J 18 Suppl 3:28-30
  160. Shibabaw T (2020). Inflammatory Cytokine: IL-17A Signaling pathway in patients present with COVID-19 and current treatment strategy. J Inflamm Res 13:673-680
  161. Marone G, Columbo M, de Paulis A, Cirillo R, Giugliano R, Condorelli M (1986). Physiological concentrations of zinc inhibit the release of histamine from human basophils and lung mast cells. Agents Actions 18(1-2):103-6
  162. Feltis BN, Elbaz A, Wright PF, Mackay GA, Turney TW, Lopata AL (2015). Characterizing the inhibitory action of zinc oxide nanoparticles on allergic- type mast cell activation. Mol Immunol 66(2):139-46
  163. Gueck T, Seidel A, Fuhrmann H (2003). Effects of essential fatty acids on mediators of mast cells in culture. Prostaglandins Leukot Essent Fatty Acids 68(5):317-22
  164. Park BK, Park S, Park JB, Park MC, Min TS, Jin M (2013). Omega-3 fatty acids suppress Th2-associated cytokine gene expressions and GATA transcription factors in mast cells. J Nutr Biochem 24(5):868-76
  165. Yip KH, Kolesnikoff N, Yu C, Hauschild N, Taing H, Biggs L, et al (2014). Mech,anisms of vitamin D3 metabolite repression of IgE-dependent mast cell activation. J Allergy Clin Immunol 133(5):1356-64
  166. Liu ZQ, Li XX, Qiu SQ, Yu Y, Li MG, Yang LT, et al (2017). Vitamin D contributes to mast cell stabilization. Allergy 72(8):1184-1192
  167. Zhao JW, Ping JD, Wang YF, Liu XN, Li N, Hu ZL, et al (2020). Vitamin D suppress the production of vascular endothelial growth factor in mast cell by inhibiting PI3K/Akt/p38 MAPK/HIF-1a pathway in chronic spontaneous urticaria. Clin Immunol 215:108444
  168. Takemoto S, Yamamoto A, Tomonaga S, Funaba M, Matsui T (2013). Magnesium deficiency induces the emergence of mast cells in the liver of rats. J Nutr Sci Vitaminol (Tokyo) 59(6): 560-3
  169. Ohbori K, Fujiwara M, Ohishi A, Nishida K, Uozumi Y, Nagasawa K (2017). Prophylactic oral administration of magnesium ameliorates dextran sulfate sodium-induced colitis in mice through a decrease of colonic accumulation of P2X7 receptor-expressing mast cells. Biol Pharm Bull 40(7):1071-1077
  170. Haase H, Rink L (2007). Signal transduction in monocytes: the role of zinc ions. Biometals 20(3-4):579-85
  171. Lu H, Xin Y, Tang Y, Shao G (2012). Zinc suppressed the airway inflammation in asthmatic rats: effects of zinc on generation of eotaxin, MCP-1, IL-8, IL-4, and IFN-y. Biol Trace Elem Res 150(1-3):314-21
  172. Cho E, Park Y (2016). Association between serum fatty acid composition and innate immune markers in healthy adults. Nutr Res Pract 10(2):182-7
  173. Snodgrass RG, Huang S, Namgaladze D, Jandali O, Shao T, Sama S, et al (2016). Docosahexaenoic acid and palmitic acid reciprocally modulate monocyte activation in part through endoplasmic reticulum stress. J Nutr Biochem 32:39-45
  174. Sugimoto J, Romani AM, Valentin-Torres AM, Luciano AA, Ramirez Kitchen CM, Funderburg N, et al (2012). Magnesium decreases inflammatory cytokine production: a novel innate immunomodulatory mechanism. J Immunol 188(12):6338-46
  175. Sun L, Li X, Xu M, Yang F, Wang W, Niu X (2020). In vitro immunomodulation of magnesium on monocytic cell toward antiinflammatory macrophages. Regen Biomater 7(4):391-401
  176. Aude-Garcia C, Dalzon B, Ravanat JL, Collin-Faure V, Diemer H, Strub JM, et al (2016). A combined proteomic and targeted analysis unravels new toxic mechanisms for zinc oxide nanoparticles in macrophages. J Proteomics 134:174-185
  177. Zhao G, Etherton TD, Martin KR, Vanden Heuvel JP, Gillies PJ, West SG, et al (2005). Anti-inflammatory effects of polyunsaturated fatty acids in THP-1 cells. Biochem Biophys Res Commun 336(3):909-17
  178. Rao Z, Zhang N, Xu N, Pan Y, Xiao M, Wu J, et al (2017). 1,25- Dihydroxyvitamin D inhibits LPS-induced high-mobility group box 1 (HMGB1) secretion via targeting the NF-E2-related factor 2- hemeoxygenase-1-HMGB1 pathway in macrophages. Front Immunol 8:1308
  179. Helming L, Bose J, Ehrchen J, Schiebe S, Frahm T, Geffers R, et al (2005). 1alpha,25-Dihydroxyvitamin D3 is a potent suppressor of interferon gamma-mediated macrophage activation. Blood 106(13):4351-8
  180. Karkeni E, Morin SO, Bou Tayeh B, Goubard A, Josselin E, Castellano R, et al (2019). Vitamin D controls tumor growth and CD8+ T cell infiltration in breast cancer. Front Immunol 10:1307
  181. Turner DL, Ford WR, Kidd EJ, Broadley KJ, Powell C (2017). Effects of nebulised magnesium sulphate on inflammation and function of the guinea- pig airway. Eur J Pharmacol 801:79-85
  182. Hu T, Xu H, Wang C, Qin H, An Z (2018). Magnesium enhances the chondrogenic differentiation of mesenchymal stem cells by inhibiting activated macrophage-induced inflammation. Sci Rep 8(1): 3406
  183. Finamore A, Massimi M, Conti Devirgiliis L, Mengheri E (2008). Zinc deficiency induces membrane barrier damage and increases neutrophil transmigration in Caco-2 cells. J Nutr 138(9):1664-70
  184. Sakakibara Y, Sato S, Kawashima Y, Someya Y, Shirato K, Tachiyashiki K, et al (2011). Different recovery responses from dietary zinc-deficiency in the distribution of rat granulocytes. J Nutr Sci Vitaminol (Tokyo) 57(2):197- 201
  185. Yoshida S, Yasutomo K, Watanabe T (2016). Treatment with DHA/EPA ameliorates atopic dermatitis-like skin disease by blocking LTB4 production. J Med Invest 63(3-4):187-91
  186. Chang YF, Hou YC, Pai MH, Yeh SL, Liu JJ (2017). Effects of q-3 polyunsaturated fatty acids on the homeostasis of CD4+ T cells and lung injury in mice with polymicrobial sepsis. J Parenter Enteral Nutr 41(5):805- 814
  187. Akbas EM, Gungor A, Ozcicek A, Akbas N, Askin S, Polat M (2016). Vitamin D and inflammation: evaluation with neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio. Arch Med Sci 12(4):721-7
  188. Tang Y, Liu J, Yan Y, Fang H, Guo C, Xie R, et al (2018). 1,25- dihydroxyvitamin-D3 promotes neutrophil apoptosis in periodontitis with type 2 diabetes mellitus patients via the p38/MAPK pathway. Medicine (Baltimore) 97(52):e13903

- - - - - more in PDF - - - - -


Created by admin. Last Modification: Wednesday September 15, 2021 13:08:34 GMT-0000 by admin. (Version 19)

Attached files

ID Name Comment Uploaded Size Downloads
15709 Story T4.jpg admin 04 Jun, 2021 17:34 263.61 Kb 601
15708 Story T3.jpg admin 04 Jun, 2021 17:33 260.47 Kb 616
15707 Story T2.jpg admin 04 Jun, 2021 17:33 203.77 Kb 605
15706 Story T1.jpg admin 04 Jun, 2021 17:33 205.39 Kb 656
15705 zinc, ω-3 polyunsaturated fatty acids, vitamin D and magnesium for prevention and treatment_compressed.pdf PDF 2021 admin 04 Jun, 2021 16:54 442.31 Kb 67
See any problem with this page? Report it (FINALLY WORKS)